FI
TBIO

Fosun International’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Fosun International’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-60,683
Closed -$780K – 318
2019
Q2 		$780K Sell
60,683
-54,805
-47% -$578K 0.05% 192
2019
Q1 		$1.14M Buy
115,488
+41,488
+56% +$318K 0.07% 148
2018
Q4 		$545K Buy
+74,000
New +$542K 0.03% 208

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Fosun International's TBIO Position: Q3 2019 in Review

Fosun International sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2019, closing a stake of 60,683 shares — an estimated $780K sold.

Fosun International first reported a position in TBIO in Q4 2018 and held it in 3 quarters. The position peaked at $1.14M in Q1 2019. 67 funds tracked by Wall St. Rank hold TBIO as of Q3 2019.

  • Fosun International reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Fosun International sold 60,683 Translate Bio, Inc. Common Stock shares in Q3 2019, an estimated $780K.
  • Fosun International first reported a position in Translate Bio, Inc. Common Stock in Q4 2018 and held it in 3 quarters.
  • Fosun International's Translate Bio, Inc. Common Stock position peaked at $1.14M in Q1 2019.
  • 67 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2019.

Based on Fosun International's 13F filing for Q3 2019, filed 12 Nov 2019.